Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE6D | O43924 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | CASP1 | P29466 | 1/20 | 0.31 |
| ▸ | CASP7 | P55210 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.30 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22945054 | 0.97 | PDE6D (0.34) | PDE6DCYP1A2ALDH1A1TP53HPGD | |
| SCHEMBL22945334 | 0.94 | PDE6D (0.37) | PDE6DALDH1A1TP53HPGDTSHR | |
| SCHEMBL22945629 | 0.94 | PDE6D (0.32) | PDE6DALDH1A1TP53HPGDTSHR | |
| SCHEMBL22945488 | 0.94 | S1PR5 (0.33) | PDE6DALDH1A1TP53HPGDTSHR | |
| SCHEMBL22945977 | 0.93 | PDE6D (0.38) | PDE6DALDH1A1TP53HPGDTSHR | |
| SCHEMBL22945179 | 0.93 | PDE6D (0.39) | PDE6DCYP1A2ALDH1A1TP53HPGD | |
| SCHEMBL22945055 | 0.92 | PDE6D (0.31) | PDE6D | |
| SCHEMBL22945640 | 0.92 | PDE6D (0.35) | PDE6D | |
| SCHEMBL22945487 | 0.91 | ALOX5 (0.37) | PDE6DALOX5 | |
| SCHEMBL15089014 | 0.90 | PDE6D (0.37) | PDE6DCYP1A2ALDH1A1TP53HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11812658-B2 | Compound and organic light emitting diode comprising same | LG CHEM, LTD. (KR) | 2023-11-07 | — | — | US | disclosed |
| US-11812658-B2 | Compound and organic light emitting diode comprising same | LG CHEM, LTD. (KR) | 2023-11-07 | — | — | US | disclosed |
| US-20210036236-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME | LG CHEM, LTD. (KR) | 2021-02-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210036236-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME | DRD1, DRD3, DRD2 | PDE6D 342/4885CYP1A2 206/4885ALDH1A1 271/4885 |
| US-11812658-B2 | Compound and organic light emitting diode comprising same | DRD1, DRD3, DRD2 | PDE6D 342/4885CYP1A2 206/4885ALDH1A1 271/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.